Cullen/Frost Bankers, Inc. Ideaya Biosciences, Inc. Transaction History
Cullen/Frost Bankers, Inc.
- $8.43 Billion
- Q3 2025
A detailed history of Cullen/Frost Bankers, Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 93 shares of IDYA stock, worth $2,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93Holding current value
$2,938% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IDYA
# of Institutions
223Shares Held
83.5MCall Options Held
28.7KPut Options Held
132K-
Black Rock Inc. New York, NY6.81MShares$215 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.55MShares$207 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.21MShares$196 Million0.07% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.03MShares$159 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$156 Million0.0% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.52B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...